Generic Name and Formulations:
Oxybutynin 3.9mg/day; transdermal patch.
Indications for OXYTROL:
Overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
Apply to clean, dry area on the abdomen, hip, or buttock. 1 patch twice weekly (every 3–4 days). Rotate application sites.
Urinary or gastric retention, uncontrolled narrow-angle glaucoma; or patients at risk for these.
Bladder outflow or GI obstruction. Hepatic or renal impairment. Ulcerative colitis. Intestinal atony. Hiatus hernia/GERD. Discontinue if skin hypersensitivity or angioedema develops; consider discontinuing if anticholinergic CNS effects occur. Avoid in myasthenia gravis; discontinue if symptoms occur. Exposure to high environmental temperature. Pregnancy. Nursing mothers.
CNS depression potentiated by alcohol, other CNS depressants. Additive effects with other anticholinergics. May affect GI absorption of other drugs. Caution with drugs that cause or exacerbate esophagitis (eg, bisphosphonates).
Local reactions, anticholinergic effects (eg, dry mouth, constipation, dizziness, abnormal vision, somnolence, confusion, hallucinations), headache, diarrhea, rash.